Navigation Links
MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX™ in FREEDOM-301 Trial
Date:10/29/2010

triptan analyses. Factors found to affect the rate of recurrence in the triptan meta-analyses include gender of the patient, age group (below 35 and above 35), and severity of headache pain at the time of treatment (moderate vs. severe). In this analysis, both age and severity of pain at time of treatment were associated with higher recurrence rates in the placebo group.

A second new analysis, "The Major Metabolite of Dihydroergotamine (DHE) After Oral Inhalation and IV Administration Does Not Significantly Contribute to the Pharmacological Activity," analyzed results of two studies and showed that the pharmacologic contribution of DHE's primary metabolite is minimal.

The seven other analyses to be presented include:

  • LEVADEX, a Novel Orally Inhaled Treatment for Acute Migraine: Efficacy and Tolerability Results of a Phase 3 Study (#462)
  • Efficacy Evaluation of LEVADEX in Treating a Broad Spectrum of Acute Migraine Attacks (#463)
  • Efficacy Evaluation of LEVADEX in Treating Resistant Migraine Including Migraine with Allodynia, Morning Migraine, Disabling Migraine and Migraine Treated Late (#464)
  • Utility of LEVADEX in Situations Where Early Intervention Paradigm is Impractical (#322)
  • Evaluation of Safety and Efficacy of LEVADEX (MAP0004) in Treating Acute Menstrual Migraine (#465)
  • Evaluation of Efficacy and Safety of LEVADEX (MAP0004) in Reversing Central Sensitization and Treating Migraine in Established Allodynic Patients (#466)
  • The Efficacy and Tolerability of LEVADEX (Orally Inhaled DHE) for the Treatment of Migraine in Subjects with Concomitant Asthma (#467)

    • About LEVADEX™ LEVADEX orally inhaled migraine therapy is a novel migraine therapy in Phase 3 development. Patients administer LEVADEX themselves using the company's proprietary TEMPO® inhaler. LEVADEX has been designed to be differentiated from existing migraine treatments. It is a novel formulation of dihydroergot
    '/>"/>

    SOURCE MAP Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4

    Related medicine technology :

    1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
    10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
    11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/23/2013)...  Haemonetics Corporation (NYSE: HAE ) announced today ... Development, will present at The Deutsche Bank 38 th ... on May 29, 2013 at 1:30pm Eastern time.  ... The public may access Mr. Lindop,s presentation live via webcast ... Haemonetics (NYSE: HAE ) is a global ...
    (Date:5/23/2013)... Hearing health affects a man,s lifestyle, and if ... and professionally engaged, he should address any hearing loss he ... Better Hearing Institute (BHI) is delivering to men ... Week , which leads up to and includes Father,s Day. ... through June 16. To help men address ...
    (Date:5/23/2013)... 23, 2013  A recently published clinical study conducted ... Texas , demonstrates that 3D mammography (breast tomosynthesis) ... The study, "Implementation of Breast Tomosynthesis ... led by Stephen L. Rose , ... American Journal of Roentgenology (AJR). The AJR ...
    Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3
    ... This Week , a leading industry publication, has honored Amedica®/US ... for Spine Care in 2010 . Amedica/US Spine, ... unique silicon nitride (SiN) ceramic technologies, received recognition in the ... Valeo® AL Lumbar Spacer and Best New Technology in ...
    ... CareTech Solutions, an information technology and Web products ... hospitals, announced today that the Detroit Medical Center ... document imaging solution, iDoc™, for the eight-facility integrated ... "As the largest healthcare provider in southeast Michigan, ...
    Cached Medicine Technology:Two Amedica®/US Spine® Implant Products Receive Best New Technology Awards from Orthopedics This Week 2Detroit Medical Center Chooses CareTech Solutions' Document Imaging System 2
    (Date:5/24/2013)... 2013 Part guidebook, part memoir, Peter ... tried and true approach to meditation for the recovery ... the 11th Step, the book outlines a comprehensive method ... the 11th step in any 12-step recovery programs such ... dependence an ever-growing global health problem affecting the physical ...
    (Date:5/24/2013)... Lima, Ohio (PRWEB) May 24, 2013 Range ... to “Take Care of the Customer, from the President's desk ... to perform with honesty and integrity, and having passion while ... important to us as a company to do the right ... cause to donate to those affected by devastation. , Throughout ...
    (Date:5/24/2013)... New York (PRWEB) May 24, 2013 ... 2010 DePuy hip recall continue to move forward in ... According to documents filed in California’s San Francisco Superior ... seeking an expedited trial of her DePuy hip lawsuit ... v. DePuy Orthopaedics, Inc., et al., No. CGC11508806; Calif. ...
    (Date:5/24/2013)... 2013 ResortQuest Real Estate® is proud ... Feher team at the firm’s Bethany Beach location. , ... her home in 1975. Her real estate career began ... aspects of the real estate business - receptionist, cleaning ... years, a licensed sales associate. , “I am ...
    (Date:5/24/2013)... New research suggests a link between sleep duration ... Every additional hour someone with insomnia sleeps is ... likelihood of moderate or high risk of suicide, ... "We were surprised by the strength ... risk," study author, Linden Oliver, clinical research coordinator ...
    Breaking Medicine News(10 mins):Health News:Guidebook for Recovery Published by Meditation Master Peter Amato 2Health News:Guidebook for Recovery Published by Meditation Master Peter Amato 3Health News:Range Kleen Partners with Berndes in Red Cross Promotion: Taking Care of Oklahoma 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2
    ... Chiltern, a leading global research,organization announced ... its,suite of clinical trial management applications providing ... collection and management of,electronic clinical trial data. ... DataLabs EDC system according to 21CRF Part ...
    ... Special Delivery Unit at The Children,s,Hospital of Philadelphia, ... diagnosed birth defects, PHILADELPHIA, June 22 ... Children,s Hospital of Philadelphia for,the 12th Annual Fetal ... have been followed by the Center for Fetal ...
    ... are calling on Louisiana Governor Jindal to veto a ... SB 312 was quietly,pushed through the legislature by PR ... are asking Jindal to use his veto in,the interest ... discussion,but they were not., Fluoride is added to ...
    ... (formerly,Diagnostic Ultrasound Corp.), the maker of BladderScan(R) bladder ... selection, for the second year in a row, ... in Washington State by Washington CEO Magazine., ... as the 4th "Best Company To Work For" ...
    ... Pa., June 20 The Department of,Agriculture is recommending ... Dairy farm in New Salem, York County, discard it ... Dennis Wolff said today., Raw milk is milk ... farms to sell raw milk, but requires they obtain,permits ...
    ... A recent study by Best,Practices, LLC found that ... Introduction team was one of the most important ... New Product Launch,Through Effective Processes and Authority Roles, ... optimize their launch governance groups and,maximize the success ...
    Cached Medicine News:Health News:Chiltern Enhances Its Portfolio of Electronic Data Capture (EDC) Services With the Addition of Hosting and eCRF Design Services for DataLabs (by ClinPhone) and Medidata Rave(R) Certification 2Health News:12th Annual Fetal Surgery Family Reunion Gathers Families From Across the U.S. and Canada 2Health News:12th Annual Fetal Surgery Family Reunion Gathers Families From Across the U.S. and Canada 3Health News:Professionals Ask Governor Jindal to Veto Unfair Fluoridation Bill 2Health News:Verathon Inc., Recognized, Second Year Running, as Outstanding Workplace in Washington State by Washington CEO Magazine 2Health News:PA Agriculture Department Warns Consumers About Raw Milk Sold by York County Dairy 2Health News:Ensuring a Successful New Product Launch Through Effective Processes and Authority Roles 2
    ... a brief magnetic pulse to stimulate deep ... in Magnetic Nerve Stimulators. Based upon equipment ... in 1985. A powerful monophasic stimulator for ... best stimulator for Central Motor Conduction Studies, ...
    ... surgical approach to glaucoma management that employs ... ciliary body (which produces aqueous humour) is ... or posterior segment, through the endoscope in ... and accurately identified utilizing endoscopy. This allows ...
    ... Endoscopic CycloPhotocoagulation (ECP) is a surgical approach ... and visualized laser application. The ciliary body ... the surgeon, from the anterior or posterior ... The target tissues are easily and accurately ...
    ... is a surgical approach to glaucoma management ... application. The ciliary body (which produces aqueous ... the anterior or posterior segment, through the ... are easily and accurately identified utilizing endoscopy. ...
    Medicine Products: